NASDAQ, CYCCP - Cyclacel Pharmaceuti
In this report, ??Cyclacel,?? the ??Company,?? ??we,?? ??us,?? and ??our?? refer
to Cyclacel Pharmaceuticals, Inc.
General
Cyclacel Pharmaceuticals, Inc. ??Cyclacel?? or the ??Company?? was incorporated
in the state of Delaware in 1996 and is headquartered in Berkeley Heights, New
Jersey with research facilities located in Dundee, Scotland and Cambridge,
England. Cyclacel is a development-stage biopharmaceutical company dedicated to
the discovery, development and commercialization of novel, mechanism-targeted
drugs to treat human cancers and other serious disorders. We market directly in
the U.S. Xclair? Cream for radiation dermatitis and Numoisyn? Liquid and
Numoisyn? Lozenges for xerostomia through our wholly-owned subsidiary ALIGN
Pharmaceuticals, LLC. ...
Read SEC Filing on NASDAQ.com »